• Aucun résultat trouvé

[PDF] Top 20 Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients.

Has 10000 "Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients." found on our website. Below are the top 20 most common "Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients.".

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients.

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients.

... of HIV-HCV coinfection ...mg in HCV monoinfected patients was predictive of sustained virological response (SVR) and proposed a threshold of 1755 ...discriminate ... Voir le document complet

8

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort

... chronic HCV infection in our patients (median 14 (8–22) years), no association was observed with HCV-related variables such as HCV transmission group, duration of HCV ... Voir le document complet

12

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

... modeled HCV transmission among HIV- infected patients only, without considering any other route of transmission such as from the monoinfected HCV ...population. In a sensitivity ... Voir le document complet

12

Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.: Non invasive fibrosis indexes in HIV-HCV coinfected patients

Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.: Non invasive fibrosis indexes in HIV-HCV coinfected patients

... used in clinical practice in HCV monoinfected patients (25, 26), data on the performance of these tests in HIV- HCV coinfected patients are ...evaluated ... Voir le document complet

24

Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.

Hepatic steatosis in HIV-HCV coinfected patients in France: comparison with HCV monoinfected patients matched for body mass index and HCV genotype.

... consistent with those of previous reports and of a recent meta-analysis in 3068 patients [27], lending further validity to our ...compared with the total group of 427 HCV ... Voir le document complet

29

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies

... develops in 60% of untreated HEV-infected patients ...that patients with hematologic malignancies are also at risk for chron- ic HEV ...SOT patients showed a high response rate to ... Voir le document complet

5

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study

... safety in the second prospective cohort treated with IFN-free regimens with DAAs Patient characteristics are detailed in Table 4 ...consecutive patients with B-NHL prospec- ... Voir le document complet

17

Does HCV screening of blood donors affect transmission of hepatitis G virus in dialysed patients?

Does HCV screening of blood donors affect transmission of hepatitis G virus in dialysed patients?

... (ALT) in 10 of 13 HGV RNA-positive patients were ...3 patients with elevated ALT levels, 1 was coinfected with HBV (HBeAg-positive), the second with HCV, and the third had ... Voir le document complet

2

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality.

... participating in the West African and Southern African regions of the International epidemiological Databases to Evaluate AIDS (IeDEA) ...programmes in four sub-Saharan African countries, including two ... Voir le document complet

11

Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients.: Non-HDL cholesterol and atherosclerosis in HIV patients.

Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients.: Non-HDL cholesterol and atherosclerosis in HIV patients.

... of HIV-positive (HIV+) patients and has improved their quality of life 1 ...to HIV infection per se and/or to c-ART has raised clinical and public health concerns 2-5 given the increasing ... Voir le document complet

38

Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients.

Acoustic Radiation Force Impulse (ARFI) and Transient Elastography (TE) for evaluation of liver fibrosis in HIV-HCV co-infected patients.

... 46 patients, 14 (30%) showed discordant Metavir scores between the two methods, 11 in predicting F ≥ 2 and three in predicting F ≥ ...associated with these discordances were analyzed, ... Voir le document complet

9

Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions

Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions

... variables, in order to compare characteristics of patients at enrollment in terms of HCV risk ...on HCV risk practices was assessed using a Logistic mixed ...associated with ... Voir le document complet

11

Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients

Efficacy and safety of hepatitis C direct-acting protease inhibitors (DAA-PI ) in real life in HIV-HCV coinfected patients

... 31 patients were analyzed, 5 Naives and 26 re-treatments (21% relapsers, 53% non responders and 26% intolerance ...male with a 49 years old’s mean age. Mode of transmission of HIV& HCV was ... Voir le document complet

2

Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions

Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions

... However, in a study on a prevention intervention for couples where one or both partners were PWID, El- Bassel et ...of HIV and HCV, respectively 28% and 75%, and that a quarter of those who tested ... Voir le document complet

11

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study

... the patients’ declaration to their physician, and classified as follows: never, past non-excessive, past excessive, current non-excessive and current ...of HIV transmission, presence of cART, Acquire immune ... Voir le document complet

22

Study of HCV and HIV infections in Mali: Comparative Epidemiology and Risk Factors

Study of HCV and HIV infections in Mali: Comparative Epidemiology and Risk Factors

... of HCV and HIV infections in Mali: Comparative Epidemiology and Risk Factors Nouhoum Sama Bouare 1 *, Dolores Vaira 1 , Andre Gothot 1 , Jean Delwaide 1 , Lorence Seidel 1 , Paul Gerard 2 , Andre ... Voir le document complet

1

IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C

IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C

... assessed in the validation sample (excluding patients who were RR) using the same ...SVRs in the total group (screen + validation, excluding RR ...Covariates with a p-value ...analysis. ... Voir le document complet

20

HIV control programs reduce HIV incidence but not HCV incidence among people who inject drugs in HaiPhong, Vietnam

HIV control programs reduce HIV incidence but not HCV incidence among people who inject drugs in HaiPhong, Vietnam

... 1,9 in Vietnam, harm reduction programs to control HiV among people who inject drugs (pWiD) were implemented approximately 10 years ...the HIV prevalence has declined in this population, ... Voir le document complet

9

Are patients with HBV and HCV infection different? Comparison between 2 cohorts of newly diagnosed cases included in prospective registries of the Belgian Association for the Study of the Liver

Are patients with HBV and HCV infection different? Comparison between 2 cohorts of newly diagnosed cases included in prospective registries of the Belgian Association for the Study of the Liver

... evolving in western ...of patients newly diagnosed with HBV or HCV infections have not been ...of patients with newly diagnosed HBV or HCV infection in Belgium, and ... Voir le document complet

1

Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: a real-life experience from Belgium

Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: a real-life experience from Belgium

... Sofosbuvir in combination with simeprevir +/- ribavirin in genotype 4 hepatitis C patients with advanced fibrosis or cirrhosis: real-life experience from Belgium Christophe ... Voir le document complet

1

Show all 10000 documents...